All In Biotech

Drug Trial Radar · NCT06388564

A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 130 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

130

Actual

Start

Oct 11, 2024

Primary completion

Oct 1, 2026

Study completion Mar 30, 2029

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
Apr 29, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will be conducted to determine the preliminary efficacy of axatilimab in combination with ruxolitinib and to assess the contribution of axatilimab to the combination treatment effect in participants with cGVHD.

Conditions

  • Chronic Graft-versus-host-disease

Interventions

  • AxatilimabDrug

    Axatilimab will be administered at protocol defined dose.

  • RuxolitinibDrug

    Ruxolitinib will be administered at protocol defined dose.

  • CorticosteroidsDrug

    Corticosteroids will be administered at protocol defined dose.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response RateTime frame: 6 months

Locations

68 sites in 7 countries. Site status is shown where the registry gives one.

  • Mayo Clinic Hospital

    Phoenix, Arizona

  • City of Hope Medical Center

    Duarte, California

  • University of California-Los Angeles Medl Cntr-Oncology Center Bowyer Clinic

    Los Angeles, California

  • Stanford Cancer Center

    Stanford, California

  • University of Colorado Cancer Center

    Aurora, Colorado

  • Colorado Blood Cancer Institute

    Denver, Colorado

  • Smilow Cancer Center-Yale

    New Haven, Connecticut

  • Mayo Clinic Jacksonville

    Jacksonville, Florida

  • Northwestern University

    Chicago, Illinois

  • The University of Chicago Medicine

    Chicago, Illinois

  • University of Maryland-Greenebaum Cancer Center

    Baltimore, Maryland

  • Washington University

    St Louis, Missouri

  • Fred and Pamela Buffett Cancer Center

    Omaha, Nebraska

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Weill Cornell Medicine

    New York, New York

  • Mount Sinai Hospital

    New York, New York

  • Cleveland Clinic

    Cleveland, Ohio

  • The Ohio State University

    Columbus, Ohio

  • University of Pennsylvania Abramson Cancer Center

    Philadelphia, Pennsylvania

  • Hillman Cancer Center

    Pittsburgh, Pennsylvania

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • Md Anderson Cancer Center

    Houston, Texas

  • Fred Hutchinson Cancer Center

    Seattle, Washington

  • University of Washington

    Seattle, Washington

  • Froedtert & the Medical College of Wisconsin

    Milwaukee, Wisconsin

  • Az Sint-Jan Brugge - Oostende Av - Campus Sint-Jan

    Bruges, Belgium

  • Universitair Ziekenhuis Antwerpen (Uza)

    Edegem, Belgium

  • Jessa Ziekenhuis

    Hasselt, Belgium

  • Universitair Ziekenhuis (Uz) Leuven

    Leuven, Belgium

  • Universitaire Ziekenhuis Leuven - Gasthuisberg

    Leuven, Belgium

  • Centre Hospitalier Universitaire (Chu) de Liege

    Liège, Belgium

  • AZ DELTA

    Roeselare, Belgium

  • Vancouver General Hospital

    Vancouver, Canada

  • Arthur J E Child Comprehensive Cancer Centre

    Calgary, Alberta, Canada

  • Princess Margaret Cancer Centre - University Health Network

    Toronto, Ontario, Canada

  • Chu Sainte-Justine

    Montreal, Quebec, Canada

  • Klinikum Der Johann Wolfgang Goethe University

    Frankfurt am Main, Germany

  • Universitatklinikum Freiburg

    Freiburg I. Breisgau, Germany

  • Universitatsklinikum Hamburg Eppendorf

    Hamburg, Germany

  • Universitaetsklinikum Jena

    Jena, Germany

Showing 40 of 68 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.